CClinicalTrials.gg
RecruitingNCT06036498NIRS L/CUpdated Sep 14, 2023

Evaluation of Cerebral Blood Flow and Cerebral Oxygenation With Transcranial Doppler and NIRS in Laparoscopic Cholecystectomy Cases

An observational study in Cerebral Hypoperfusion, Cerebral Occlusion and Cholecystitis; Gallstone, sponsored by Uludag University. Recruiting at 1 site in Turkey. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-09-14.

Sponsored by Uludag University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
40
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The goal of this clinical trial is to test intracranial blood flow and cerebral oxygenisation changes in patients who have pneumoperitoneum in laparoscopic cholecystectomy procedure.

The main questions aim to answer are:

  • How does pneumoperitoneum in laparoscopic cholecystectomy procedure changes blod flow in patients?
  • Are there any differences between Near-Red spectroscopy and transcranial doppler ultrasonography assesment?

Participants will be diagnosed with using NIRS probes and Doppler ultrasonography probes if any changes in surgical procedure.

Researchers will compare NIRS and TCD detection outcomes to see if there is any differences.

Read the detailed description

Laparoscopic cholecystectomy is the gold standard treatment method for benign gallbladder stones. The required pneumoperitoneum for the operation leads to hemodynamic and metabolic changes in patients. Prolonged complicated laparoscopic surgeries also pose an additional risk factor for neurological complications.

Cerebral circulation occurs within a closed environment enclosed by the skull. This environment includes brain tissue, blood volume, and cerebrospinal fluid. Cerebral blood pressure arises from the difference between arterial blood pressure and intracranial pressure. Due to carbondioxide insufflation in laparoscopic surgery, caused by pneumoperitoneum creation, intra-abdominal carbondioxide is rapidly absorbed through the peritoneal membrane and enters the bloodstream.

Carbonic acid formed by the carbonic anhydrase enzyme in the plasma leads to respiratory acidosis. The resulting respiratory acidosis triggers peripheral and central vasodilation to ensure oxygenation and gas exchange, causing a rightward shift in the hemoglobin curve. Hypercarbia's impact on cells and the effect of cellular acidosis lead to local tissue edema. All of these factors contribute to changes in transcranial pressure. An increase in intracranial pressure can result in impaired cerebral perfusion.

Transcranial Doppler (TCD) is a reliable tool for imaging intracranial pressure due to its affordability, non-invasiveness, repeatability at the bedside, and real-time data provision during acute situations. Transcranial Doppler ultrasonography (TCD) can better display flow velocity waveforms, flow direction, intraparenchymal flow velocity, and density compared to other diagnostic tests. Changes in waveforms detected by TCD allow tracking changes in intracranial pressure. However, assessing tissue oxygenation solely with transcranial Doppler ultrasonography is not feasible.

Near-Infrared Spectroscopy (NIRS) can play an effective role in showing tissue oxygen perfusion for this purpose. NIRS imaging, similar to pulse oximetry, utilizes infrared light between 650 and 1000 nm to measure oxyhemoglobin levels in tissues and capillaries. Its non-invasiveness, ease of tolerance by the patient, and ability to quickly detect sudden drops in oxygen levels in tissues make it reliable.

In this study, Researchers aimed at implementing in patients planned for laparoscopic cholecystectomy, intend to use TCD and NIRS protocols to detect changes in intracranial blood flow and cerebral tissue oxygenation during the preoperative, intraoperative, and postoperative periods.

02

Conditions studied

  • Cerebral Hypoperfusion
  • Cerebral Occlusion
  • Cholecystitis; Gallstone
  • Cholecystitis/Cholelithiasis

Keywords

  • Near Infra-Red Spectrophotometry
  • Cerebral Oxygenisation
  • Transcranial Doppler Ultrasonography (TCD)
  • Laparoscopic Surgery
03

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Patients who has;

  • Cholelithiasis,
  • Gallbladder Stones,
  • Diagnosed with acute cholecystitis

Inclusion criteria

  • Patients with American Society of Anesthesiology (ASA) 1-3 classification,
  • Both male and female patients between the ages of 18 to 65,
  • Patients scheduled for elective laparoscopic cholecystectomy.

Exclusion criteria

Exclusion Criteria:

  • American Society of Anesthesiology (ASA) 4 and above patient groups,
  • Patients aged under 18 and over 65,
  • Patients with a history of known previous cerebrovascular accident (CVA),
  • Patients with follow-up due to Cerebrovascular Ischemic Brain Attack Syndrome (CIBAS),
  • Patients diagnosed with Carotid Stenosis,
  • Patients diagnosed with peripheral and central vascular diseases,
  • Patients with general debilitation and extreme senility,
  • Cases that require conversion to laparotomy during the intraoperative period.
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
40 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Preoperative Assessment of Trail Group

    Device: Near Infrared Spectrophotometry Device, Transcranial Doppler Ultrasonography

  • Post-Anaesthetic Induction Assessment of Trial Groups

    Device: Near Infrared Spectrophotometry Device, Transcranial Doppler Ultrasonography

  • After Pneumoperitoneum Assessment of Trial Groups

    Device: Near Infrared Spectrophotometry Device, Transcranial Doppler Ultrasonography

  • Within Head-up Tilt Position Assessment of Trial Groups

    Device: Near Infrared Spectrophotometry Device, Transcranial Doppler Ultrasonography

  • Neuralized Position Assessment of Trial Groups

    Device: Near Infrared Spectrophotometry Device, Transcranial Doppler Ultrasonography

  • Within Deflation of Abdomen Assessment of Trial Groups

    Device: Near Infrared Spectrophotometry Device, Transcranial Doppler Ultrasonography

  • Awaking Period from Anaesthesia Assessment of Trial Groups

    Device: Near Infrared Spectrophotometry Device, Transcranial Doppler Ultrasonography

Interventions

  • DeviceNear Infrared Spectrophotometry Device, Transcranial Doppler Ultrasonography

    We will get signals from the NIRS probes which are positioned bitemporal region of forehead in same time testing intracranial blood flow via TCD device.

    Also known as: NIRS, iNVOS Spectrophotometry

05

What researchers measure

Primary outcomes

  1. Detecting Cerebral Blood Flow Changes at Pneumoperitoneum Time via New Assessment Methods

    In this study, aimed at patients scheduled for laparoscopic cholecystectomy, Researchers intend to utilize transcranial doppler ultrasonography to detect changes in intracranial blood flow changes during the preoperative, intraoperative, and postoperative periods.

    Time frame: Perioperative Time in Laparoscopic Cholecystectomy Surgery Procedures

  2. Detecting Cerebral Tissue Oxygenisation Changes at Pneumoperitoneum Time via New Assessment Methods

    In this study, aimed at patients scheduled for laparoscopic cholecystectomy, Researchers intend to utilize Near Infrared spectrophotometry methods to detect oxygenisation changes in cerebral hemispheres during the preoperative, intraoperative, and postoperative periods.

    Time frame: Perioperative Time in Laparoscopic Cholecystectomy Surgery Procedures

Other outcomes

  1. Detecting any difference between Near Infrared Spectrophotomery and Transcranial Doppler

    Researchers will compete Near Infrared spectrophotometry and transcranial doppler ultrasonography methods in cerebral hemodynamics in perioperative process in laparoscopic cholecystectomy patients.

    Time frame: Perioperative Time in Laparoscopic Cholecystectomy Surgery Procedures

06

Study locations

1 of 1 sites recruiting
  • Bursa Uludag University, Faculty of Medicine, Department of Anesthesiology and Reanimation
    Bursa, Nilufer 16285, Turkey
    Recruiting
07

Registry details

Key details

Study ID
NCT06036498
Lead sponsor
Uludag University
Responsible party
Kadir Bugra Basaran (Medical Doctor, Research Assistant at Department of Anesthesiology and Reanimation, Uludag University) — Principal investigator
First posted
Sep 14, 2023
Start date
Jan 18, 2023
Primary completion
Jun 1, 2024 (estimated)
Completion
Jun 26, 2024 (estimated)
Last update
Sep 14, 2023

Study contacts

Kadir Bugra Basaran
Contact
kbugrabasaran@gmail.com
+905422780016
Kadir Bugra Basaran
study chair · Uludag University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion